Bristol-Myers Squibb Company:企業の戦略・SWOT・財務情報

◆英語タイトル:Bristol-Myers Squibb Company - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4431
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:69
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Bristol-Myers Squibb Company – Strategy, SWOT and Corporate Finance Report
Summary

Bristol-Myers Squibb Company – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Bristol-Myers Squibb Company (BMS or ‘the company’) is a global biopharmaceutical company. The company is involved in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines in various therapeutic areas that primarily include cardiovascular; virology, oncology, and immunoscience. The company’s major brands include Baraclude, Sustiva, Reyataz, Opdivo, Eliquis, Orencia, Sprycel, Yervoy and Empliciti. The company operates across the Americas, Europe, Asia, Australia, and other regions of the world. BMS is headquartered in New York City, New York.

Scope

- Detailed information on Bristol-Myers Squibb Company required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bristol-Myers Squibb Company in the form of a SWOT analysis
- An in-depth view of the business model of Bristol-Myers Squibb Company including a breakdown and examination of key business segments
- Intelligence on Bristol-Myers Squibb Company’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bristol-Myers Squibb Company, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Bristol-Myers Squibb Company and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Bristol-Myers Squibb Company as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Bristol-Myers Squibb Company’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Bristol-Myers Squibb Company: Company Overview 9
Bristol-Myers Squibb Company: Overview and Key Facts 9
Bristol-Myers Squibb Company: Overview 9
Bristol-Myers Squibb Company: Key Facts 9
Bristol-Myers Squibb Company: Key Employees 11
Bristol-Myers Squibb Company: Key Employee Biographies 13
Bristol-Myers Squibb Company: Major Products and Services 19
Bristol-Myers Squibb Company: Company History 20
Bristol-Myers Squibb Company: Management Statement 32
Bristol-Myers Squibb Company: Locations and Subsidiaries 35
Bristol-Myers Squibb Company: Key Competitors 36
Bristol-Myers Squibb Company: Company Analysis 37
Bristol-Myers Squibb Company: Business Description 37
Bristol-Myers Squibb Company: SWOT Analysis 39
Bristol-Myers Squibb Company: SWOT Overview 39
Bristol-Myers Squibb Company: Strengths 39
Bristol-Myers Squibb Company: Weaknesses 40
Bristol-Myers Squibb Company: Opportunities 41
Bristol-Myers Squibb Company: Threats 42
Bristol-Myers Squibb Company: Corporate Financial Deals Activity 44
Bristol-Myers Squibb Company: Financial Deals Overview 44
Bristol-Myers Squibb Company: Targets and Partners 46
Bristol-Myers Squibb Company: Top Deals 2014 – 2018YTD* 51
Bristol-Myers Squibb Company: Advisors 52
Bristol-Myers Squibb Company: Top Legal Advisors 52
Bristol-Myers Squibb Company: Mergers and Acquisitions 53
Bristol-Myers Squibb Company: Corporate Venturing 54
Bristol-Myers Squibb Company: Partnership 55
Bristol-Myers Squibb Company: Divestments 56
Bristol-Myers Squibb Company: Recent Developments 57
Bristol-Myers Squibb Company: News and Events Summary 57
Bristol-Myers Squibb Company: Contracts 61
Bristol-Myers Squibb Company: Corporate Governance 62
Bristol-Myers Squibb Company: Financial Deals 63
Bristol-Myers Squibb Company: Financial Performance 63
Bristol-Myers Squibb Company: Grants 63
Bristol-Myers Squibb Company: Market Developments 64
Bristol-Myers Squibb Company: Regulatory and Legal Events 65
Bristol-Myers Squibb Company: Research & Development 66
Appendix 67
Contact Us 67
Methodology 67
About MarketLine 68

List of Tables
Table 1: Bristol-Myers Squibb Company: Key Facts
Table 2: Bristol-Myers Squibb Company: Key Employees
Table 3: Bristol-Myers Squibb Company: Locations and Subsidiaries
Table 4: Bristol-Myers Squibb Company: Key Competitors
Table 5: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Bristol-Myers Squibb Company: M&A Activity by Geography (TTM*)
Table 7: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Bristol-Myers Squibb Company: M&A Average Deal Size - Value (US$m)
Table 9: Bristol-Myers Squibb Company: Targets and Partners
Table 10: Bristol-Myers Squibb Company: Top Deals 2014 - 2018YTD*
Table 11: Bristol-Myers Squibb Company: Legal Advisor Ranking by Value (US$m)
Table 12: Bristol-Myers Squibb Company: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Bristol-Myers Squibb Company: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Bristol-Myers Squibb Company: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: Bristol-Myers Squibb Company: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: Bristol-Myers Squibb Company: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: Bristol-Myers Squibb Company: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: Bristol-Myers Squibb Company: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 19: Bristol-Myers Squibb Company: News and Events Summary
Table 20: Bristol-Myers Squibb Company: Contracts
Table 21: Bristol-Myers Squibb Company: Corporate Governance
Table 22: Bristol-Myers Squibb Company: Financial Deals
Table 23: Bristol-Myers Squibb Company: Financial Performance
Table 24: Bristol-Myers Squibb Company: Grants
Table 25: Bristol-Myers Squibb Company: Market Developments
Table 26: Bristol-Myers Squibb Company: Regulatory and Legal Events
Table 27: Bristol-Myers Squibb Company: Research & Development

List of Figures
Figure 1: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Bristol-Myers Squibb Company: M&A Activity by Geography (TTM*)
Figure 3: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Bristol-Myers Squibb Company: M&A Average Deal Size - Value (US$m)
Figure 5: Bristol-Myers Squibb Company: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Bristol-Myers Squibb Company: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Bristol-Myers Squibb Company: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Bristol-Myers Squibb Company: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Bristol-Myers Squibb Company: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: Bristol-Myers Squibb Company: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 11: Bristol-Myers Squibb Company: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Bristol-Myers Squibb Company:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Meridian Energy Limited:企業の戦略・SWOT・財務分析
    Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bank Gutmann AG:企業の戦略・SWOT・財務情報
    Bank Gutmann AG - Strategy, SWOT and Corporate Finance Report Summary Bank Gutmann AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Neuraltus Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Neuraltus Pharmaceuticals Inc (Neuraltus) is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of neurodegenerative diseases. The company offers products under clinical development that include NP001 and others. Neuraltus’ focuses on macrophage which …
  • Landauer Inc (LDR):企業の財務・戦略的SWOT分析
    Summary Landauer Inc (Landauer), a subsidiary of Fortive Corp, is a medical device company that manufactures and distributes integrated radiation safety products. The company provides professional medical physics, occupational radiation monitoring, and medical products. Its products include dosimete …
  • Izumi Co., Ltd.:戦略・SWOT・企業財務分析
    Izumi Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Izumi Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Ventas Inc:企業のM&A・事業提携・投資動向
    Ventas Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ventas Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Banco Comercial Portugues S.A:企業のM&A・事業提携・投資動向
    Banco Comercial Portugues S.A - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco Comercial Portugues S.A Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Seek Limited:企業の戦略・SWOT・財務分析
    Seek Limited - Strategy, SWOT and Corporate Finance Report Summary Seek Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Domino’s Pizza, Inc.:企業の戦略・SWOT・財務分析
    Domino's Pizza, Inc. - Strategy, SWOT and Corporate Finance Report Summary Domino's Pizza, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Tokyu Corp:企業の戦略・SWOT・財務分析
    Tokyu Corp - Strategy, SWOT and Corporate Finance Report Summary Tokyu Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Steward Health Care System LLC:企業の戦略的SWOT分析
    Steward Health Care System LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Lotus Pharmaceutical Co Ltd (1795):企業の財務・戦略的SWOT分析
    Summary Lotus Pharmaceutical Co Ltd (Lotus Pharmaceutical), a subsidiary of Alvogen Inc is a pharmaceutical company that develops and sells pharmaceutical products. The company provides products that are used in the treatment of rheumatology, cancer, cardiology, dyslipidemia, hypertension, woman hea …
  • Pon Holdings B.V.:企業のM&A・事業提携・投資動向
    Pon Holdings B.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pon Holdings B.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Northstar Aerospace Inc.:企業の戦略・SWOT・財務情報
    Northstar Aerospace Inc. - Strategy, SWOT and Corporate Finance Report Summary Northstar Aerospace Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Dynacq Healthcare Inc (DYII):企業の財務・戦略的SWOT分析
    Summary Dynacq Healthcare Inc (DHI) is a healthcare consulting organization that provides surgical services. The organization develops and manages general acute hospitals that provide general surgeries. Its hospitals are designed to handle operations such as orthopaedics, neurosurgery and general su …
  • Peptilogics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Peptilogics Inc (Peptilogics) is an early-stage biotechnology company that develops novel peptide therapeutics. The company’s antibiotics address the epidemic of multidrug-resistant bacterial infections. Its products portfolio includes engineered Cationic Antibiotic Peptides (eCAP) technolog …
  • Alphabet Inc:戦略・SWOT・企業財務分析
    Alphabet Inc - Strategy, SWOT and Corporate Finance Report Summary Alphabet Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • bioMerieux SA (BIM)-医療機器分野:企業M&A・提携分析
    Summary bioMerieux S.A. (bioMerieux) designs, develops and manufactures diagnostic systems and reagents for physicians and biologists. The company offers diagnostic solutions such as instruments, reagents and software. bioMerieux products are used diagnosing and managing infectious diseases, cardiov …
  • Arab Petroleum Investments Corp:企業の戦略的SWOT分析
    Arab Petroleum Investments Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Midea Group Co Ltd:戦略・SWOT・企業財務分析
    Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆